Olgu Sunumu
BibTex RIS Kaynak Göster

İnatçı Gastroözofageal Kavşak Dieulafoy Lezyonunun İntraoperatif Endoskopik Dövme ile Cerrahi Tedavisi

Yıl 2026, Cilt: 17 Sayı: 1 , 37 - 40 , 31.03.2026
https://doi.org/10.33706/jemcr.1777562
https://izlik.org/JA37FW52JW

Öz

Giriş: Dieulafoy lezyonu (DL), üst gastrointestinal kanamanın nadir görülen ancak potansiyel olarak yaşamı tehdit eden bir nedenidir. Endoskopik tedavi ilk basamak tedavidir; ancak tekrarlayan kanama cerrahi müdahaleyi gerektirebilir.
Olgu Sunumu: 55 yaşında erkek hasta hematemez ve hemodinamik instabilite ile acil servise başvurdu. İlk endoskopide mide fundusundaki aktif kanamalı Dieulafoy lezyonu görüldü. Hemostaz, epinefrin enjeksiyonu, termal koagülasyon ve hemoklip yerleştirilmesi ile sağlandı ve kan transfüzyonundan sonra geçici stabilizasyon sağlandı. Hastanedeki üçüncü günde, tekrarlayan kanama tekrar endoskopi ve ek bir hemoklip uygulaması gerektirdi, ancak hasta semptomlarını yaşamaya devam etti. Sekizinci günde, metilen mavisi ile intraoperatif endoskopik dövmeleme lezyonun doğru lokalizasyonunu kolaylaştırdı ve kama rezeksiyonu yapıldı. Ameliyat sonrası süreç sorunsuz geçti ve histopatolojik inceleme DL tanısını doğruladı.
Sonuç: Bu olgu, refrakter Dieulafoy lezyonlarında intraoperatif endoskopik işaretlemenin değerli bir yardımcı olduğunu, hassas lokalizasyona olanak sağladığını, gereksiz radikal cerrahiden kaçınılmasını sağladığını ve başarılı sınırlı rezeksiyona izin verdiğini göstermektedir.

Etik Beyan

Hasta, özgür ve bilgilendirilmiş onam formunu imzalamıştır.

Kaynakça

  • Nojkov B, Cappell MS. Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc. 2015 Apr 16;7(4):295–307. doi: 10.4253/wjge.v7.i4.295
  • Gallard Lee, Y. T., Walmsley, R. S., Leong, R. W. L., & Sung, J. J. Y. (2003). Dieulafoy’s lesion. Gastrointestinal Endoscopy, 58(2), 236–243. doi:10.1067/mge.2003.328
  • Chen W, Chen P, Li X, Gao X, Li J. Clinical characteristics and treatments for bronchial Dieulafoy’s disease. Respir Med Case Rep. 2019 Jan 7;26:229-235. doi: 10.1016/j.rmcr.2019.01.004. PMID: 30740302; PMCID: PMC6357209
  • Veldhuyzen van Zanten, S. J., Bartelsman, J. F., Schipper, M. E., & Tytgat, G. N. (1986). Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut, 27(2), 213–222. doi:10.1136/gut.27.2.213
  • Jeon HK, Kim GH. Endoscopic Management of Dieulafoy’s Lesion. Clin Endosc. 2015 Mar;48(2):112-20. doi: 10.5946/ce.2015.48.2.112. Epub 2015 Mar 27. PMID: 25844338; PMCID: PMC4381137.
  • Baxter M, Aly EH. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010 Oct;92(7):548-54. doi: 10.1308/003588410X1269966390531 1. PMID: 20883603; PMCID: PMC3229341.
  • Norton, I. D., Petersen, B. T., Sorbi, D., Balm, R. K., Alexander, G. L., & Gostout, C. J. (1999). Management and long-term prognosis of Dieulafoy lesion. Gastrointestinal Endoscopy, 50(6), 762–767. doi:10.1016/s0016-5107(99)70155-0
  • Saleh R, Lucerna A, Espinosa J, Scali V. Dieulafoy lesion: the little known sleeping giant of gastrointestinal bleeds. Am J Emerg Med. 2016 Dec;34(12):2464.e3-2464.e5.
  • Shin HJ, Ju JS, Kim KD, Kim SW, Kang SH, Kang SH, Moon HS, Sung JK, Jeong HY. Risk Factors for Dieulafoy Lesions in the Upper Gastrointestinal Tract. Clin Endosc. 2015 May;48(3):228-33. doi: 10.5946/ce.2015.48.3.228. Epub 2015 May 29.
  • Ding YJ, Zhao L, Liu J, Luo HS. Clinical and endoscopic analysis of gastric Dieulafoy’s lesion. World J Gastroenterol. 2010 Feb 7;16(5):631-5. doi: 10.3748/wjg.v16.i5.631.
  • Baettig B, Haecki W, Lammer F, Jost R. Dieulafoy’s disease: endoscopic treatment and follow up. Gut. 1993 Oct;34(10):1418-21. doi: 10.1136/gut.34.10.1418. PMID: 8244112; PMCID: PMC1374553
  • Aabdi B, Kharrasse G, Zazour A, Koulali H, Elmqaddem O, Zahi I. Clinical, endoscopic and therapeutic features of bleeding Dieulafoy’s lesions: case series and literature review. BMJ Open Gastroenterol. 2024 May 24;11(1):e001299. doi: 10.1136/bmjgast-2023-001299. PMID: 38789268; PMCID: PMC11129027.
  • Levy AR, Broad S, Loomis Iii JR, Thomas JA. Diagnosis and Treatment of a Recurrent Bleeding Dieulafoy’s Lesion: A Case Report. Cureus. 2022 Nov 30;14(11):e32051. doi: 10.7759/cureus.32051. PMID: 36600857; PMCID: PMC9802011.
  • Zhiwei, Zhang, and Chen Junqiang. “Laparoscopy and methylene blue staining angiography for precise synchronous resection of small intestinal vascular malformations: A case report.” Frontiers in Medicine 12 (2025): 1621874.

Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing

Yıl 2026, Cilt: 17 Sayı: 1 , 37 - 40 , 31.03.2026
https://doi.org/10.33706/jemcr.1777562
https://izlik.org/JA37FW52JW

Öz

Introduction: Dieulafoy’s lesion (DL) is a rare but potentially life-threatening cause of upper gastrointestinal bleeding. Endoscopic therapy is the first-line treatment; however, recurrent bleeding may necessitate surgical intervention.
Case Report:A 55-year-old male presented to the emergency department with hematemesis and hemodynamic instability. Initial endoscopy revealed a Dieulafoy’s lesion in the gastric fundus with active bleeding. Hemostasis was achieved with epinephrine injection, thermal coagulation, and hemoclip placement, and temporary stabilization was obtained after blood transfusion. On the third hospital day, recurrent bleeding required repeat endoscopy and an additional hemoclip application, but the patient continued to experience symptoms. On day eight, intraoperative endoscopic tattooing with methylene blue facilitated accurate localization of the lesion, and wedge resection was performed. The postoperative course was uneventful, and histopathological examination confirmed the diagnosis of DL.
Conclusion:This case demonstrates that intraoperative endoscopic marking is a valuable adjunct in refractory Dieulafoy’s lesions, enabling precise localization, avoiding unnecessary radical surgery, and allowing successful limited resection.

Etik Beyan

The patient signed the free and informed consent form.

Kaynakça

  • Nojkov B, Cappell MS. Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc. 2015 Apr 16;7(4):295–307. doi: 10.4253/wjge.v7.i4.295
  • Gallard Lee, Y. T., Walmsley, R. S., Leong, R. W. L., & Sung, J. J. Y. (2003). Dieulafoy’s lesion. Gastrointestinal Endoscopy, 58(2), 236–243. doi:10.1067/mge.2003.328
  • Chen W, Chen P, Li X, Gao X, Li J. Clinical characteristics and treatments for bronchial Dieulafoy’s disease. Respir Med Case Rep. 2019 Jan 7;26:229-235. doi: 10.1016/j.rmcr.2019.01.004. PMID: 30740302; PMCID: PMC6357209
  • Veldhuyzen van Zanten, S. J., Bartelsman, J. F., Schipper, M. E., & Tytgat, G. N. (1986). Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut, 27(2), 213–222. doi:10.1136/gut.27.2.213
  • Jeon HK, Kim GH. Endoscopic Management of Dieulafoy’s Lesion. Clin Endosc. 2015 Mar;48(2):112-20. doi: 10.5946/ce.2015.48.2.112. Epub 2015 Mar 27. PMID: 25844338; PMCID: PMC4381137.
  • Baxter M, Aly EH. Dieulafoy’s lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010 Oct;92(7):548-54. doi: 10.1308/003588410X1269966390531 1. PMID: 20883603; PMCID: PMC3229341.
  • Norton, I. D., Petersen, B. T., Sorbi, D., Balm, R. K., Alexander, G. L., & Gostout, C. J. (1999). Management and long-term prognosis of Dieulafoy lesion. Gastrointestinal Endoscopy, 50(6), 762–767. doi:10.1016/s0016-5107(99)70155-0
  • Saleh R, Lucerna A, Espinosa J, Scali V. Dieulafoy lesion: the little known sleeping giant of gastrointestinal bleeds. Am J Emerg Med. 2016 Dec;34(12):2464.e3-2464.e5.
  • Shin HJ, Ju JS, Kim KD, Kim SW, Kang SH, Kang SH, Moon HS, Sung JK, Jeong HY. Risk Factors for Dieulafoy Lesions in the Upper Gastrointestinal Tract. Clin Endosc. 2015 May;48(3):228-33. doi: 10.5946/ce.2015.48.3.228. Epub 2015 May 29.
  • Ding YJ, Zhao L, Liu J, Luo HS. Clinical and endoscopic analysis of gastric Dieulafoy’s lesion. World J Gastroenterol. 2010 Feb 7;16(5):631-5. doi: 10.3748/wjg.v16.i5.631.
  • Baettig B, Haecki W, Lammer F, Jost R. Dieulafoy’s disease: endoscopic treatment and follow up. Gut. 1993 Oct;34(10):1418-21. doi: 10.1136/gut.34.10.1418. PMID: 8244112; PMCID: PMC1374553
  • Aabdi B, Kharrasse G, Zazour A, Koulali H, Elmqaddem O, Zahi I. Clinical, endoscopic and therapeutic features of bleeding Dieulafoy’s lesions: case series and literature review. BMJ Open Gastroenterol. 2024 May 24;11(1):e001299. doi: 10.1136/bmjgast-2023-001299. PMID: 38789268; PMCID: PMC11129027.
  • Levy AR, Broad S, Loomis Iii JR, Thomas JA. Diagnosis and Treatment of a Recurrent Bleeding Dieulafoy’s Lesion: A Case Report. Cureus. 2022 Nov 30;14(11):e32051. doi: 10.7759/cureus.32051. PMID: 36600857; PMCID: PMC9802011.
  • Zhiwei, Zhang, and Chen Junqiang. “Laparoscopy and methylene blue staining angiography for precise synchronous resection of small intestinal vascular malformations: A case report.” Frontiers in Medicine 12 (2025): 1621874.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Acil Tıp, Gastroenteroloji ve Hepatoloji
Bölüm Olgu Sunumu
Yazarlar

Aşkın Kadir Perçem 0000-0002-6726-2422

Ramazan Topcu 0000-0001-6214-4868

Orhan Aslan 0000-0002-1982-0792

Mahmut Arif Yüksek 0000-0002-8323-7390

İsmail Sezikli 0000-0002-6801-1465

Gönderilme Tarihi 3 Eylül 2025
Kabul Tarihi 12 Ocak 2026
Yayımlanma Tarihi 31 Mart 2026
DOI https://doi.org/10.33706/jemcr.1777562
IZ https://izlik.org/JA37FW52JW
Yayımlandığı Sayı Yıl 2026 Cilt: 17 Sayı: 1

Kaynak Göster

APA Perçem, A. K., Topcu, R., Aslan, O., Yüksek, M. A., & Sezikli, İ. (2026). Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports, 17(1), 37-40. https://doi.org/10.33706/jemcr.1777562
AMA 1.Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 2026;17(1):37-40. doi:10.33706/jemcr.1777562
Chicago Perçem, Aşkın Kadir, Ramazan Topcu, Orhan Aslan, Mahmut Arif Yüksek, ve İsmail Sezikli. 2026. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports 17 (1): 37-40. https://doi.org/10.33706/jemcr.1777562.
EndNote Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ (01 Mart 2026) Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports 17 1 37–40.
IEEE [1]A. K. Perçem, R. Topcu, O. Aslan, M. A. Yüksek, ve İ. Sezikli, “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”, Journal of Emergency Medicine Case Reports, c. 17, sy 1, ss. 37–40, Mar. 2026, doi: 10.33706/jemcr.1777562.
ISNAD Perçem, Aşkın Kadir - Topcu, Ramazan - Aslan, Orhan - Yüksek, Mahmut Arif - Sezikli, İsmail. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports 17/1 (01 Mart 2026): 37-40. https://doi.org/10.33706/jemcr.1777562.
JAMA 1.Perçem AK, Topcu R, Aslan O, Yüksek MA, Sezikli İ. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 2026;17:37–40.
MLA Perçem, Aşkın Kadir, vd. “Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing”. Journal of Emergency Medicine Case Reports, c. 17, sy 1, Mart 2026, ss. 37-40, doi:10.33706/jemcr.1777562.
Vancouver 1.Aşkın Kadir Perçem, Ramazan Topcu, Orhan Aslan, Mahmut Arif Yüksek, İsmail Sezikli. Surgical Treatment of a Refractory Gastroesophageal Junction Dieulafoy Lesion Using Intraoperative Endoscopic Tattooing. Journal of Emergency Medicine Case Reports. 01 Mart 2026;17(1):37-40. doi:10.33706/jemcr.1777562